# Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/atezolizumab-in-combination-with-carboplatin-and-nab-paclitaxel-in-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert M. Jotte,Federico Cappuzzo,Ihor Vynnychenko,Daniil Stroyakovskiy,Delvys Rodríguez‐Abreu,Maen Hussein,Ross A. Soo,Henry Jacob Conter,Toshiyuki Kozuki,Kuan-Chieh Huang,Vilma Graupner,Shawn W. Sun,Tien Hoang,Helen Jessop,Mark L. McCleland,Marcus Ballinger,Alan Sandler,Mark A. Socinski |
| Citations | 614 |
| DOI | 10.1016/j.jtho.2020.03.028 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.jto.org/article/S1556086420302926/pdf |
| OpenAlex ID | https://openalex.org/W3017322331 |
| PMID | 32302702 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Ross A. Soo](https://scholariq.org/researchers/ross-a-soo/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.